Form 4 for EW Edwards Lifesciences
Accepted 2026-05-05 19:08:09 ET · period of report 2026-05-03 · accession 0001225208-26-004969 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-05-05 19:08 | 2026-05-03+ | EW | Ullem Scott B. | CFO, CVP | F - Tax | $82.97 | -11.8K | 40.9K | -22% | -$974.9K |
| D | 2026-05-05 19:08 | 2026-05-05 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $59.26 | +13.0K | 52.1K | +33% | +$770.3K |
| D | 2026-05-05 19:08 | 2026-05-05 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $0.00 | -13.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-03 | F | D | 620 | $83.98 | 39,079 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-05 | M | A | 13,000 | $59.26 | 52,079 | D | — | — | |
| 3 | Common | Common Stock | 2026-05-05 | F | D | 11,131 | $82.91 | 40,948 | D | — | — | |
| 4 | Derivative | Employee Stock Option (Right to Acquire) | 2026-05-05 | M | D | 13,000 | $0.00 | 0 | D | $59.26 · 2020-05-08 to 2026-05-07 | 13,000 Common Stock |